Atara Biotherapeutics
ATRA
ATRA
109 hedge funds and large institutions have $131M invested in Atara Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-9
Holders Change %
-7.63%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
42
Reduced
38
Closed
20
Calls
$1.82M
Puts
$98K
Net Calls
+$1.72M
Net Calls Change
-$471K
Top Buyers
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$1.23M |
| 2 |
2
Millennium Management
New York
|
$484K |
| 3 |
3
BlackRock
New York
|
$11.4M |
| 4 |
4
D.E. Shaw & Co
New York
|
$5.79M |
| 5 |
5
Goldman Sachs
New York
|
$6.1M |
